Hair Loss Treatment Manufacturing - Market Research Report

Thick and thin: A patent cliff will threaten major firms, but revenue will continue to grow

Hair Loss Treatment Manufacturing

Cutting its losses

Despite being a discretionary product, demand for hair loss treatments has remained relatively strong. Revenue for hair loss treatment manufacturers will grow steadily over the next five years, supported by a patent cliff for major products Rogaine and Propecia. While the companies that manufacture these products will likely face a decline in profit, consumers will purchase more generic hair loss treatments. Furthermore, the aging population will increase the instances of male pattern baldness, boosting demand.

This industry develops and produces solutions that prevent or restore hair loss. Products in this industry include topical applications, orally ingestible treatments, hair transplants and laser follicle stimulation.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.